If you wish to join the litigation, go to http://www.rosenlegal.com/cases-register-1545.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. When the true details entered the market, the lawsuit claims that investors suffered damages. [email protected]. Synergy investors have an opportunity to recover their investment losses. Contact: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) from September 5, 2017 through November 14, 2017, inclusive. New York, N.Y., April 8, 2019. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. SYNERGY APRIL 12th DEADLINE ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Synergy Pharmaceuticals Inc.; Encourages Investors With Losses In Excess of $100K to Contact the Firm – SGYP. To join the Synergy class action, go to http://www.rosenlegal.com/cases-register-1545.html or call Phillip Kim, Esq. Rosen Law Firm was Ranked No. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Synergy Pharmaceuticals Inc. (NASDAQ: SGYP) from September 5, 2017 through October 25, 2018, inclusive (the “Class Period”). NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. The Rosen Law Firm, P.A. Laurence Rosen, Esq. SAFIRSTEIN METCALF LLP - ATTORNEY ADVERTISING. Shareholders Foundation, Inc. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 lrosen@rosenlegal.com pkim@rosenlegal.com cases@rosenlegal.com www.rosenlegal.com. The lawsuit seeks recovery of investor losses. Michael Daniels Email us OR fill out the form below for a free case evaluation, 1-800-221-0015 БК 1xBet. YOU MAY RETAIN COUNSEL OF YOUR CHOICE. The Shareholders Foundation, Inc. is not a law firm. An investor, who purchased shares of Synergy Pharmaceuticals Inc (NASDAQ: SGYP), filed a lawsuit over alleged violations of Federal Securities Laws by Synergy Pharmaceuticals Inc in connection with certain allegedly false and misleading statements. Safirstein Metcalf LLP Announces that a Class Action has been Filed Against Synergy Pharmaceuticals Inc – SGYP. An investor in shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Synergy Pharmaceuticals Inc in connection with certain allegedly false and misleading statements made between September 5, 2017 and November 14, 2017. Safirstein Metcalf LLP announces that a class action lawsuit has been filed against Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) and certain of its officers, on behalf of shareholders who purchased Synergy securities during the class period between September 5, 2017 … View ComplaintRetainer Agreementinfo@rosenlegal.com. Phone: +1-(858)-779-1554 The firm has been ranked in the top 3 each year since 2013. Terms and Conditions. The lawsuit seeks to recover damages for Synergy investors under the federal securities laws. NASDAQ: SGYP investors should contact the Shareholders Foundation at [email protected] or call +1(858) 779 – 1554.
Live Streaming Traffic Cameras, How To Become A Business Analyst With No Experience, Nba Players That Went To Gonzaga, Umich Canvas, Okeechobee Police Department Jobs, Alhosn University Salary, Goddess Pele Lover,